FINHUB Insights

MRK · Q3 FY24 · Jul 1 – Sep 30, 2024

Merck & Q3 FY24: where the revenue came from and where it went

Merck & Q3 FY24: revenue $16.7B (+4% year over year). Net profit $3.2B. Largest cohort US $8.7B. The whole income statement as a sankey diagram from the SEC filing.

Period
Jul 1 – Sep 30, 2024
Reported
Nov 6, 2024 10-Q
Sankey diagram of Merck &'s income statement for Q3 FY24: revenue of $16.7 billion splits into segments and flows out into costs, taxes and net profit.

Tap the diagram to enlarge · figures in billions of dollars

Revenue$16.7B +4% year over year
Gross profit$12.6B 76% margin
Operating profit$3.9B 24% margin
Net profit$3.2B 19% margin

The numbers

All figures in billions of U.S. dollars, for Q3 FY24 (period ends Sep 30, 2024).
ItemValueShare of revenueYear over year
Revenue 16.7 100% +4%
US 8.7 52% +13%
EMEA 3.6 22% +8%
CN 1 6% −40%
JP 0.9 5% −13%
Latin America 0.9 5% +5%
Asia Pacific 0.8 5% +5%
Other Countries 0.6 4% +33%
Cost of revenue−4.125%
Gross profit12.676% margin+2pp
Research & development−5.935%+14pp
SG&A−2.716%+1pp
Operating profit3.924% margin+0pp
Tax−0.9
Net profit3.219%−11pp
Filing on EDGAR More quarters of MRK

Source of the numbers: structured XBRL data from the filing (10-Q). The diagram is generated automatically and checked against EDGAR before release. How we calculate it → About and methodology.

Older quarters